Immediate Impact

2 from Science/Nature 51 standout
Sub-graph 1 of 25

Citing Papers

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
2024 Standout
The Bioavailability of Drugs—The Current State of Knowledge
2023 Standout
1 intermediate paper

Works of Mark Gohdes being referenced

Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans
2018

Author Peers

Author Last Decade Papers Cites
Mark Gohdes 67 79 36 135 99 13 344
Rajendra Singh 25 114 23 80 62 32 371
Sayed M.H. Al-Habet 49 28 40 65 67 16 316
Verena Häfner 34 79 36 51 36 8 308
Umesh Hanumegowda 49 160 14 48 35 20 370
Derrick G. Freitag 28 100 32 28 30 21 379
Berry J. Kline 85 116 56 37 23 17 372
Melanie de la Cruz 55 108 113 82 42 7 396
I. Buggia 59 48 74 52 40 7 354
J. H. Peters 62 128 44 29 30 12 391
Hettie B. Hughes 152 93 46 51 44 10 380

All Works

Loading papers...

Rankless by CCL
2026